Enhanced induction of telomerase-specific CD4+ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

Cancer Research

Volumn 62, Issue 17, 2002, Pages 5041-5048

  Su, Zhen ^a   Vieweg, Johannes ^a   Weizer, Alon Z ^a   Dahm, Philipp ^a   Yancey, Donna ^a   Turaga, Vandana ^a   Higgins, John ^a   Boczkowski, David ^a   Gilboa, Eli ^a   Dannull, Jens ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INDUCTION; ENZYME SPECIFICITY; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELPER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE; TUMOR IMMUNITY;

ANTIGENS, CD; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DNA-BINDING PROTEINS; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE ACTIVATION; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MEMBRANE GLYCOPROTEINS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TELOMERASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036735405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
2. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
3. The central role of CD4(+) T cells in the antitumor immune response
4. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN γ receptors
5. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells
6. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
7. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens
8. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
9. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
10. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease
11. Genetic polymorphism within HLA-A02: Significant allelic variation revealed in different populations
12. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
13. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
14. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity
15. The tyrosine motifs of Lamp I and LAP determine their direct and indirect targeting to lysosomes
16. N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo
17. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors
18. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells
19. Specific association of human telomerase activity with immortal cells and cancer
20. A survey of telomerase activity in human cancer
21. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
22. Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules
23. Targeting of a lysosomal membrane protein: A tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes
24. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells
25. The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway
26. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
27. Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments
28. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response
29. Telomerase in cancer: Diagnostic, prognostic, and therapeutic implications
30. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
31. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation